B. Riley Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Buy
3,654
+62
+2% +$21.2K 0.07% 249
2026
Q1
$1.25M Sell
3,592
-809
-18% -$288K 0.08% 245
2025
Q4
$1.44M Buy
4,401
+160
+4% +$50.8K 0.07% 265
2025
Q3
$1.2M Sell
4,241
-1,657
-28% -$481K 0.06% 303
2025
Q2
$1.65M Buy
+5,898
New +$1.67M 0.08% 246
2024
Q4
$7.72M Sell
29,617
-4,194
-12% -$1.24M 0.25% 88
2024
Q3
$10.8M Sell
33,811
-6,316
-16% -$2.07M 0.3% 68
2024
Q2
$12.5M Sell
40,127
-3,080
-7% -$905K 0.32% 59
2024
Q1
$11.6M Buy
43,207
+3,028
+8% +$886K 0.31% 67
2023
Q4
$11.6M Sell
40,179
-3,028
-7% -$825K 0.31% 61
2023
Q3
$11.6M Sell
43,207
-56,581
-57% -$14.1M 0.31% 67
2023
Q2
$22.2M Buy
99,788
+62,634
+169% +$14.5M 0.5% 40
2023
Q1
$8.98M Buy
37,154
+593
+2% +$146K 0.24% 87
2022
Q4
$9.6M Sell
36,561
-5,593
-13% -$1.5M 0.27% 79
2022
Q3
$9.5M Buy
42,154
+12,016
+40% +$2.91M 0.29% 76
2022
Q2
$7.33M Buy
30,138
+4,904
+19% +$1.2M 0.31% 72
2022
Q1
$6.1M Buy
25,234
+1,648
+7% +$379K 0.2% 109
2021
Q4
$5.31M Sell
23,586
-656
-3% -$138K 0.15% 144
2021
Q3
$5.16M Sell
24,242
-7,233
-23% -$1.66M 0.16% 136
2021
Q2
$7.67M Buy
31,475
+1,929
+7% +$475K 0.25% 83
2021
Q1
$7.35M Buy
29,546
+6,776
+30% +$1.62M 0.26% 85
2020
Q4
$5.24M Buy
22,770
+8,942
+65% +$2.06M 0.28% 84
2020
Q3
$3.52M Buy
13,828
+18
+0.1% +$4.46K 0.19% 125
2020
Q2
$3.26M Buy
13,810
+5,414
+64% +$1.24M 0.22% 113
2020
Q1
$1.71M Buy
8,396
+2,375
+39% +$519K 0.15% 150
2019
Q4
$1.45M Sell
6,021
-233
-4% -$51.4K 0.12% 186
2019
Q3
$1.21M Sell
6,254
-202
-3% -$38.8K 0.12% 198
2019
Q2
$1.19M Buy
6,456
+553
+9% +$99K 0.13% 173
2019
Q1
$1.12M Sell
5,903
-983
-14% -$188K 0.14% 164
2018
Q4
$1.34M Sell
6,886
-552
-7% -$108K 0.19% 121
2018
Q3
$1.54M Buy
7,438
+1,096
+17% +$216K 0.18% 130
2018
Q2
$1.17M Buy
6,342
+555
+10% +$98.2K 0.15% 158
2018
Q1
$988K Sell
5,787
-2,074
-26% -$381K 0.14% 173
2017
Q4
$1.37M Buy
7,861
+1,578
+25% +$279K 0.19% 137
2017
Q3
$1.17M Buy
6,283
+737
+13% +$131K 0.19% 124
2017
Q2
$957K Buy
5,546
+911
+20% +$148K 0.17% 156
2017
Q1
$762K Sell
4,635
-140
-3% -$23.3K 0.15% 165
2016
Q4
$699K Sell
4,775
-189
-4% -$28.4K 0.14% 175
2016
Q3
$829K Buy
4,964
+643
+15% +$109K 0.16% 163
2016
Q2
$658K Sell
4,321
-515
-11% -$80.1K 0.13% 193
2016
Q1
$725K Buy
4,836
+1,765
+57% +$262K 0.17% 149
2015
Q4
$499K Buy
3,071
+222
+8% +$34.9K 0.1% 246
2015
Q3
$395K Buy
+2,849
New +$449K 0.09% 273
2015
Q1
Sell
-929
Closed -$148 633
2014
Q4
$148 Buy
+929
New +$145K ﹤0.01% 1529
2014
Q3
Sell
-1,255
Closed -$149K 710
2014
Q2
$149K Sell
1,255
-200
-14% -$23.2K 0.03% 564
2014
Q1
$179K Sell
1,455
-200
-12% -$24.3K 0.05% 423
2013
Q4
$189K Sell
1,655
-524
-24% -$59.6K 0.06% 361
2013
Q3
$244K Sell
2,179
-16
-0.7% -$1.74K 0.08% 271
2013
Q2
$217K Buy
+2,195
New +$228K 0.07% 298

Other funds holding AMGN

B. Riley Wealth Advisors's AMGN Position: Q2 2026 in Review

B. Riley Wealth Advisors increased its Amgen (AMGN) stake by 1.7% in Q2 2026, buying an estimated $21.2K and bringing the position to 3,654 shares worth $1.32M. The position accounts for 0.07% of the portfolio, ranked #249.

B. Riley Wealth Advisors first reported a position in AMGN in Q2 2013 and has held it in 49 quarters since. The position peaked at $22.2M in Q2 2023. 1,151 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • B. Riley Wealth Advisors held 3,654 shares of Amgen worth $1.32M as of Q2 2026.
  • B. Riley Wealth Advisors bought 62 Amgen shares in Q2 2026, an estimated $21.2K.
  • Amgen made up 0.07% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #249 holding.
  • B. Riley Wealth Advisors first reported a position in Amgen in Q2 2013 and has held it in 49 quarters since.
  • B. Riley Wealth Advisors's Amgen position peaked at $22.2M in Q2 2023.
  • 1,151 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.